Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

biote (BTMD) Asset Writedowns and Impairment: 2021-2024

Historic Asset Writedowns and Impairment for biote (BTMD) over the last 4 years, with FY2024 value amounting to $1.5 million.

  • biote's Asset Writedowns and Impairment rose 56575.34% to $486000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year increase of 12005.6%. This contributed to the annual value of $1.5 million for FY2024, which is 12473.6% up from last year.
  • biote's Asset Writedowns and Impairment amounted to $1.5 million in FY2024, which was up 12473.6% from $663000.0 recorded in FY2023.
  • In the past 5 years, biote's Asset Writedowns and Impairment registered a high of $1.5 million during FY2024, and its lowest value of -$155000.0 during FY2022.
  • In the last 4 years, biote's Asset Writedowns and Impairment had a median value of $567000.0 in 2021 and averaged $617250.0.
  • In the last 5 years, biote's Asset Writedowns and Impairment crashed by 13290.87% in 2022 and then surged by 52774.19% in 2023.
  • biote's Asset Writedowns and Impairment (Annual) stood at $471000.0 in 2021, then plummeted by 132.91% to -$155000.0 in 2022, then skyrocketed by 527.74% to $663000.0 in 2023, then surged by 124.74% to $1.5 million in 2024.
  • Its Asset Writedowns and Impairment stands at $1.5 million for FY2024, versus $663000.0 for FY2023 and -$155000.0 for FY2022.